http://www.pharmaceutical-technology.com/data-insights/ac-0676-accutar-biotechnology-follicular-lymphoma-likelihood-of-approval/
0
0
AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval - Pharmaceutical Technology
7/8/23 at 1:45am
Organization
Pharmaceutical Technology
Author
kgi-admin
30 words
0
Comments
AC-0676 is under clinical development by Accutar Biotechnology and currently in Phase I for Follicular Lymphoma.
You are the first to view
Create an account or login to join the discussion